2025 first_quarter Filing
Q1Expenses
$130K
Method: A
Filed
April 28, 2025
Lobbying Activities
Science/TechnologyView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Medical/Disease Research/Clinical LabsView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
LAURA EFROS